These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
62 related items for PubMed ID: 945371
1. [Structure and activity of insulin and its analogs]. Kuzuya T. Nihon Rinsho; 1976; 34(3):632-8. PubMed ID: 945371 [No Abstract] [Full Text] [Related]
2. [Insulin analogues with substitution of A1-glycine by D-amino acids and omega-amino acids (author's transl)]. Geiger R, Geisen K, Regitz G, Summ HD, Langner D. Hoppe Seylers Z Physiol Chem; 1980 Apr; 361(4):563-70. PubMed ID: 6991387 [Abstract] [Full Text] [Related]
3. The quest for a latent action insulin. Bradbury AF, Ko AS, Massey DE, Salokangas A, Smyth DG, Sabey GA, Webb FW, Stewart GA. Postgrad Med J; 1973 Dec; 49():Suppl 7:945-8. PubMed ID: 4772465 [No Abstract] [Full Text] [Related]
5. [Insulin analogs with B-chains shortened at the N-terminal end. Selective Edman degradation of the insulin B chain (author's transl)]. Geiger R, Langner D. Hoppe Seylers Z Physiol Chem; 1973 Jun; 354(10-11):1285-90. PubMed ID: 4807833 [No Abstract] [Full Text] [Related]
6. [Comparative study of physico-chemical properties of chemical structure of hemoglobin, myoglobin and tropomyosin n phylogeny]. Sukhomlinov BF. Ukr Biokhim Zh; 1970 Jun; 42(2):244-56. PubMed ID: 5511469 [No Abstract] [Full Text] [Related]
7. [Chemical structure and function of LH-RH and its analogs]. Tanizawa O, Kinugasa T, Yamaji K, Kurachi K, Fukada N. Nihon Rinsho; 1976 Jun; 34(3):609-13. PubMed ID: 819679 [No Abstract] [Full Text] [Related]
8. Alteration in the immunochemical dominance of determinants following the chemical modification of ox insulins: implications for the structure of the ox insulin monomer in solution. Hollins PJ, Nathan MM. Clin Exp Immunol; 1979 Oct; 38(1):127-34. PubMed ID: 93526 [Abstract] [Full Text] [Related]
9. [Chemical structure and spasmolytic activity of acetamide and its derivatives]. Caujolle F, Pham-Huu-Chanh, Nguyên-Dat-Xuong, Azum-Gelade MC, Phung-Van-Tô. Agressologie; 1969 Oct; 10(5):399-404. PubMed ID: 5377602 [No Abstract] [Full Text] [Related]
11. [Vasopressin--chemical structure, function and clinical use]. Yoshida S. Nihon Rinsho; 1976 Oct; 34(3):627-31. PubMed ID: 945370 [No Abstract] [Full Text] [Related]
12. [Excellence of quipazine in the characterization of serotoninergic receptors and mechanisms]. Hong E. Gac Med Mex; 1982 Apr; 118(4):158-64. PubMed ID: 7117731 [No Abstract] [Full Text] [Related]
13. [Synthesis of bradykinin analogs with D-amino acids (all-D-bradykinin and all-D-retro-bradykinin)]. Vogler K, Lanz P, Lergier W, Haefely W. Helv Chim Acta; 1966 Jan 22; 49():390-403. PubMed ID: 5904790 [No Abstract] [Full Text] [Related]
14. Human monocomponent insulin. Chemistry and characteristics. Markussen J, Damgaard U, Jørgensen KH, Sørensen E, Thim L. Acta Med Scand Suppl; 1983 Jan 22; 671():99-105. PubMed ID: 6349271 [Abstract] [Full Text] [Related]
15. [The pharmacology of eledoisin, physalaemin and their synthetic analogs--an example for the study of structure-effect relationships of peptides. II]. Stopp G, Niedrich H. Z Arztl Fortbild (Jena); 1967 Apr 01; 61(7):359-71. PubMed ID: 5592652 [No Abstract] [Full Text] [Related]
16. [Pharmacologic studies with trophosphamide (Ixoten), a new oxazaphosphorineoxide]. Brock N. Med Monatsschr; 1973 Sep 01; 27(9):390-4. PubMed ID: 4768197 [No Abstract] [Full Text] [Related]
17. [Structure and antigenic properties of myelin basic proteins]. Goranov I, Staĭkova M, Todorov D. Eksp Med Morfol; 1976 Sep 01; 15(4):195-200. PubMed ID: 65250 [No Abstract] [Full Text] [Related]